It’s that time of year again — the HIMSS Global Health Conference and Exhibition in Las Vegas!
From March 9 to 12, Glooko, the leading diabetes and glycemic management company, will showcase its connected care solutions at booth 4103 of HIMSS26, the premier event for healthcare technology and digital health innovation.
With a focus on AI, cybersecurity, interoperability, and data-driven healthcare technology, we’ll demonstrate to C-suite leaders, clinicians, and IT specialists how the comprehensive Glooko diabetes management platform and EndoTool Glucose Management System, developed by Monarch Medical Technologies, a Glooko Company, are transforming care delivery and meeting challenges across outpatient and inpatient settings.
What you’ll learn at our booth:
- How we advance clinical workflow optimization: Manual workflows and “login fatigue” are bottlenecks care teams can’t afford. Both solutions, Glooko and EndoTool, integrate directly with leading electronic health records (EHRs), including Epic, Oracle Health, MEDITECH, Greenway Health, eClinicalWorks, NextGen, and Athenahealth, to bring all diabetes, glycemic, and health data together, giving a complete view of a patient’s health in one place. Our seamless integrations eliminate the hassle of platform switching and security risks related to multiple disparate logins, passwords on sticky notes, and reused credentials, while reducing clinician burnout. Glooko is also available in the Epic Showroom for easier integration into the EHR.
- The many ways we protect patient data across our solutions: For inpatient settings, EndoTool offers secure cloud hosting on HITRUST and SOC2-certified infrastructure, as well as on-premise solutions tailored for any IT environment. On the outpatient side, the Glooko platform boasts leading security certifications and has hundreds of security protocols in place to protect patient data and ensure compliance.
- Why we’re a leader in interoperability: The Glooko digital health solution unifies the fragmented diabetes ecosystem through seamless integration with more than 200 diabetes and health monitoring devices and apps. Whether patients use a BGM, smart insulin pen, or any other device in the diabetes ecosystem, Glooko syncs patient health data with its device agnostic platform. This provides care teams with critical information in one place, enabling more informed clinical decisions.
Experience how we’re transforming diabetes across the full continuum of care
Schedule a demo with one of our experts at the show to see how your team can benefit from our innovative, secure, and interoperable healthcare technology.
EndoTool is developed and marketed by Monarch Medical Technologies, a Glooko Company. EndoTool is an FDA-cleared Class II medical device indicated for inpatient use as described in its Instructions for Use. Glooko’s diabetes management platform and EndoTool are currently independent solutions. Patient-specific refers to EndoTool’s ability to use available patient information within the hospital’s electronic medical record to provide individualized insulin dosing recommendations. Recommendations are intended to assist, not replace, clinical judgment. All treatment decisions remain the responsibility of the licensed healthcare provider.